{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:34:04Z","timestamp":1793637244659,"version":"4.5.1"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.lfs.2022.121148","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T12:15:19Z","timestamp":1667477719000},"page":"121148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"PB","title":["Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications"],"prefix":"10.1016","volume":"311","author":[{"given":"Rupinder","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0005","first-page":"579","article-title":"Complications of kidney disease","volume":"1;53","author":"Murabito","year":"2018","journal-title":"Nurs. Clin."},{"issue":"13","key":"10.1016\/j.lfs.2022.121148_bb0010","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"1;322","author":"Chen","year":"2019","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.lfs.2022.121148_bb0015","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2146\/ajhp160559","article-title":"Considerations and controversies in managing chronic kidney disease: an update","volume":"74","author":"Prasad-Reddy","year":"2017","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0020","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s10157-018-1567-1","article-title":"Independent regulation of renin\u2013angiotensin\u2013aldosterone system in the kidney","volume":"22","author":"Nishiyama","year":"2018","journal-title":"Clin. Exp. Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J. Vet. Intern. Med."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171028","article-title":"Effects of different phosphate lowering strategies in patients with CKD on laboratory outcomes: a systematic review and NMA","volume":"12","author":"Sekercioglu","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD) foreword","volume":"7","author":"Wheeler","year":"2017","journal-title":"Kidney Int. Suppl."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0040","doi-asserted-by":"crossref","first-page":"08","DOI":"10.1159\/000099801","article-title":"Chronic kidney disease: common, harmful and treatable\u2013World Kidney Day 2007","volume":"27","author":"Levey","year":"2007","journal-title":"Am. J. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0045","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","article-title":"Nomenclature for kidney function and disease: report of a kidney disease: improving global outcomes (KDIGO) consensus conference","volume":"97","author":"Levey","year":"2020","journal-title":"Kidney Int."},{"issue":"14","key":"10.1016\/j.lfs.2022.121148_bb0050","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease: JACC state-of-the-art review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1681\/ASN.2018050531","article-title":"Projecting ESRD incidence and prevalence in the United States through 2030","volume":"30","author":"McCullough","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.lfs.2022.121148_bb0060","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0065","first-page":"2","article-title":"1. Pathophysiology and classification of kidney diseases","volume":"20","author":"Matovinovi\u0107","year":"2009","journal-title":"Ejifcc"},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41581-020-0268-7","article-title":"The impact of chronic kidney disease on global health","volume":"16","author":"Carney","year":"2020","journal-title":"Nat. Rev. Nephrol"},{"issue":"10225","key":"10.1016\/j.lfs.2022.121148_bb0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2012.01.043","article-title":"Endothelial dysfunction and cardiovascular disease in early-stage chronic kidney disease: cause or association?","volume":"223","author":"Moody","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.lfs.2022.121148_bb0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.20517\/2574-1209.2018.23","article-title":"The endothelial progenitor cell dysfunction in hypertension: the diagnostic and predictive values","volume":"2","author":"Berezin","year":"2018","journal-title":"Vessel Plus"},{"key":"10.1016\/j.lfs.2022.121148_bb0090","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3389\/fphar.2019.01568","article-title":"Role of endothelial dysfunction in cardiovascular diseases: the link between inflammation and hydrogen sulfide","author":"Sun","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2022.121148_bb0095","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4070\/kcj.2021.0995","article-title":"Vascular calcification in chronic kidney disease: distinct features of pathogenesis and clinical implication","volume":"51","author":"Kim","year":"2021","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.lfs.2022.121148_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2020.104105","article-title":"Vascular calcification: new insights into endothelial cells","volume":"134","author":"Yuan","year":"2021","journal-title":"Microvasc. Res."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0105","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/ndt\/gfy287","article-title":"High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease","volume":"34","author":"Carrillo-L\u00f3pez","year":"2019","journal-title":"Nephrol. Dial."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbadis.2016.10.027","article-title":"MicroRNAs in the pathophysiology of CKD-MBD: biomarkers and innovative drugs","volume":"1863","author":"Metzinger-Le Meuth","year":"2017","journal-title":"Biochim. Biophys. ActaMol. Basis Dis."},{"key":"10.1016\/j.lfs.2022.121148_bb0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","article-title":"The chronic kidney disease\u2014mineral bone disorder (CKD-MBD): advances in pathophysiology","volume":"100","author":"Hruska","year":"2017","journal-title":"Bone"},{"issue":"22","key":"10.1016\/j.lfs.2022.121148_bb0120","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1161\/CIRCULATIONAHA.107.743161","article-title":"Vascular calcification: pathobiology of a multifaceted disease","volume":"117","author":"Demer","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) guideline update: what's changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0130","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ndt\/gfy129","article-title":"Sclerostin in chronic kidney disease\u2013mineral bone disorder think first before you block it!","volume":"34","author":"Brandenburg","year":"2019","journal-title":"Nephrol. Dial."},{"issue":"18","key":"10.1016\/j.lfs.2022.121148_bb0135","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.18632\/aging.102297","article-title":"Fibroblast growth factor 23 expression in human calcified vascular tissues","volume":"11","author":"Donate-Correa","year":"2019","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-95488-4","article-title":"Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease","volume":"11","author":"Donate-Correa","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.121148_bb0145","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/364890","article-title":"Battaglia, clinical significance of FGF-23 in patients with CKD","author":"Russo","year":"2011","journal-title":"Int. J. Nephrol."},{"key":"10.1016\/j.lfs.2022.121148_bb0150","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fmed.2020.00154","article-title":"Vascular calcification in chronic kidney disease: the role of vitamin K-dependent matrix gla protein","volume":"7","author":"Roumeliotis","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.lfs.2022.121148_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.acc.2020.02.004","article-title":"Biomarkers of vascular calcification in serum","volume":"98","author":"Roumeliotis","year":"2020","journal-title":"Adv. Clin. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0160","first-page":"398","article-title":"Targeting vascular calcification in chronic kidney disease","volume":"5","author":"Nelson","year":"2020","journal-title":"Basic Transl. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2022.121148_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158789","article-title":"Relationship between fetuin A, vascular calcification and fracture risk in dialysis patients","volume":"11","author":"Chen","year":"2016","journal-title":"PloS one"},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0170","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/nu10050652","article-title":"Vitamin D in vascular calcification: a double-edged sword?","volume":"10","author":"Wang","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0175","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/nu11010152","article-title":"Emerging role of vitamin D and K in modulating uremic vascular calcification: the aspect of passive calcification","volume":"11","author":"Hou","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0180","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1359\/JBMR.051211","article-title":"Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function","volume":"21","author":"Bas","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.lfs.2022.121148_bb0185","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1523-1755.2003.00820.x","article-title":"Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels","volume":"63","author":"Moe","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2022.121148_bb0190","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1523-1755.2002.00170.x","article-title":"Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins","volume":"61","author":"Moe","year":"2002","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0195","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.RES.0000141775.67189.98","article-title":"Pathophysiology of vascular calcification in chronic kidney disease","volume":"95","author":"Moe","year":"2004","journal-title":"Circ. Res."},{"issue":"S1","key":"10.1016\/j.lfs.2022.121148_bb0200","first-page":"1","article-title":"Bone morphogenetic protein (BMP) transcripts in kidney tissue of cats with renal dysfunction","volume":"34","author":"Panickar","year":"2020","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0205","first-page":"15","article-title":"Serum sclerostin as a potential biomarker of vascular and valvular types of calcification in chronic kidney disease cases with and without maintenance hemodialysis","volume":"55","author":"Moghazy","year":"2019","journal-title":"Alex.J. Med"},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0210","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11255-019-02290-3","article-title":"Sclerostin: a new biomarker of CKD\u2013MBD","volume":"52","author":"Figurek","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.lfs.2022.121148_bb0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","article-title":"Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and klotho","volume":"100","author":"Yamada","year":"2017","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-018-1094-z","article-title":"The role of klotho in chronic kidney disease","volume":"19","author":"Zou","year":"2018","journal-title":"BMC Nephrol."},{"issue":"9","key":"10.1016\/j.lfs.2022.121148_bb0225","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/ndt\/gfg296","article-title":"In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1, 25 (OH) 2 vitamin D3","volume":"18","author":"Hirata","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2022.121148_bb0230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2022.121148_bb0235","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000072822","article-title":"The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients","volume":"23","author":"Chertow","year":"2003","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.lfs.2022.121148_bb0240","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/ajkd.2001.24533","article-title":"Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells","volume":"37","author":"Ahmed","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.lfs.2022.121148_bb0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.semnephrol.2003.08.014","article-title":"Vascular calcification in chronic kidney disease","volume":"24","author":"Chen","year":"2004","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.lfs.2022.121148_bb0250","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1093\/ndt\/gfz133","article-title":"Valvular heart disease and calcification in CKD: more common than appreciated","volume":"12","author":"Ure\u00f1a-Torres","year":"2020","journal-title":"Nephrol. Dial. Transplant."},{"issue":"12","key":"10.1016\/j.lfs.2022.121148_bb0255","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ki.2010.536","article-title":"Chronic Kidney Disease Prognosis Consortium. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts","volume":"79","author":"Van Der Velde","year":"2011","journal-title":"Kidney Int."},{"issue":"443","key":"10.1016\/j.lfs.2022.121148_bb0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cca.2014.10.027","article-title":"Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators","volume":"30","author":"Buglioni","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0265","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/j.ackd.2019.10.004","article-title":"Valvular calcification in chronic kidney disease","volume":"26","author":"Brandenburg","year":"2019","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"12","key":"10.1016\/j.lfs.2022.121148_bb0270","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1093\/ndt\/gft310","article-title":"Aortic valve calcification in chronic kidney disease","volume":"28","author":"Rattazzi","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2022.121148_bb0275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fendo.2012.00095","article-title":"Mechanisms and clinical consequences of vascular calcification","volume":"3","author":"Zhu","year":"2012","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0280","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00223-013-9712-z","article-title":"Vascular calcification: an update on mechanisms and challenges in treatment","volume":"93","author":"Wu","year":"2013","journal-title":"Calcif. Tissue Int."},{"issue":"1\u20134","key":"10.1016\/j.lfs.2022.121148_bb0285","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000484941","article-title":"The role of vascular calcification in heart failure and cognitive decline","volume":"5","author":"Cheng","year":"2017","journal-title":"Pulse"},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0290","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11906-012-0265-8","article-title":"Vascular calcification: pathophysiology and risk factors","volume":"14","author":"Chen","year":"2012","journal-title":"Curr. Hypertens. Rep."},{"issue":"12","key":"10.1016\/j.lfs.2022.121148_bb0295","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1093\/ndt\/gft310","article-title":"Aortic valve calcification in chronic kidney disease","volume":"28","author":"Rattazzi","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2022.121148_bb0300","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2214\/ajr.183.6.01831813","article-title":"Aortic valve calcification as a marker for aortic stenosis severity: assessment on 16-MDCT","volume":"183","author":"Koos","year":"2004","journal-title":"AJR Am. J. Roentgenol."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0305","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/ATVBAHA.107.156745","article-title":"Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification","volume":"28","author":"Liberman","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0310","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/08860220902875182","article-title":"Advanced oxidation protein products induce vascular calcification by promoting osteoblastic trans-differentiation of smooth muscle cells via oxidative stress and ERK pathway","volume":"31","author":"You","year":"2009","journal-title":"Ren. Fail."},{"issue":"22","key":"10.1016\/j.lfs.2022.121148_bb0315","doi-asserted-by":"crossref","first-page":"15319","DOI":"10.1074\/jbc.M800021200","article-title":"Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signalling","volume":"283","author":"Byon","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0320","first-page":"474","article-title":"The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease","volume":"7","author":"Amada","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"9","key":"10.1016\/j.lfs.2022.121148_bb0325","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/10715760802400766","article-title":"Superoxide production: a procalcifying cell signalling event in osteoblastic differentiation of vascular smooth muscle cells exposed to calcification media","volume":"42","author":"Sutra","year":"2008","journal-title":"Free Radic. Res."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0330","first-page":"429","article-title":"Valvular calcification and its relationship to atherosclerosis in chronic kidney disease","volume":"18","author":"Leskinen","year":"2009","journal-title":"J. Heart Valve Dis."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0335","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/CIRCINTERVENTIONS.112.971028","article-title":"Cellular mechanisms of aortic valve calcification","volume":"5","author":"Leopold","year":"2012","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0340","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/ckj\/sfv073","article-title":"Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease","volume":"8","author":"Di Lullo","year":"2015","journal-title":"Clin. Kidney J."},{"issue":"10","key":"10.1016\/j.lfs.2022.121148_bb0345","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jacc.2008.05.043","article-title":"Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans","volume":"52","author":"Miller","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0350","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/cvr\/cvab142","article-title":"Role of oxidative stress in calcific aortic valve disease and its therapeutic implications","volume":"118","author":"Greenberg","year":"2022","journal-title":"Cardiovas. Res."},{"issue":"7","key":"10.1016\/j.lfs.2022.121148_bb0355","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ekir.2020.04.022","article-title":"Elevated fibroblast growth factor 23 and decreased klotho levels are associated with diastolic dysfunction in CKD G4\u20135D patients","volume":"5","author":"Milovanova","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.lfs.2022.121148_bb0360","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/ndt\/13.8.2037","article-title":"Cardiac valve calcification in haemo-dialysis patients: role of calcium-phosphate metabolism","volume":"13","author":"Ribeiro","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2022.121148_bb0365","doi-asserted-by":"crossref","first-page":"80","DOI":"10.14740\/cr465w","article-title":"The association of calcium \u2013phosphorus product with the severity of cardiac valves failure in patients under chronic hemodialysis","volume":"7","author":"Moshar","year":"2016","journal-title":"Cardiol. Res."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0370","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2010.11.073","article-title":"Association of serum phosphate levels with aortic valve sclerosis and annular calcification:the cardiovascular health study","volume":"58","author":"Linefsky","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2022.121148_bb0375","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009804","article-title":"Risk factors for heart valve calcification in chronic kidney disease","volume":"97","author":"Rong","year":"2018","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0380","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2010.10.055","article-title":"Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients","volume":"57","author":"Kakuta","year":"2011","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0385","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1797.2010.01412.x","article-title":"Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: a pilot randomized controlled trial","volume":"16","author":"Toussaint","year":"2011","journal-title":"Nephrology"},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0390","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3\u20134 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2022.121148_bb0395","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets","volume":"81","author":"Spiegel","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2022.121148_bb0400","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2215\/CJN.06800615","article-title":"Sevelamer versus calcium-based binders for treatment of hyperphosphatemia in CKD: a meta-analysis of randomized controlled trials","volume":"11","author":"Patel","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2022.121148_bb0405","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40620-015-0228-7","article-title":"Reversible vascular calcifications associated with hypervitaminosis D","volume":"29","author":"Cirillo","year":"2016","journal-title":"J. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0410","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007146","article-title":"Computed tomography aortic valve calcium scoring in patients with aortic stenosis","volume":"11","author":"Pawade","year":"2018","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.lfs.2022.121148_bb0415","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCIMAGING.113.001508","article-title":"18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aorticstenosis","volume":"7","author":"Dweck","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.lfs.2022.121148_bb0420","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.cir.0000087660.82721.15","article-title":"Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aorticaneurysm","volume":"108","author":"Nataatmadja","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-63013-8","article-title":"Matrix gla protein is an independent predictor of both intimal and medial vascular calcification in chronic kidney disease","volume":"10","author":"Jaminon","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2022.121148_bb0430","series-title":"Current Perspectives in Kidney Diseases","first-page":"83","article-title":"Fibroblast growth factor 23: mineral metabolism and beyond","volume":"190","author":"Grabner","year":"2017"},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0435","doi-asserted-by":"crossref","first-page":"001","DOI":"10.29328\/journal.jcn.1001021","article-title":"Relationship between fetuin-a and vascular or valvular calcification in hemodialysis patients","volume":"3","author":"Ossareh","year":"2019","journal-title":"J. Clin. Nephrol."},{"key":"10.1016\/j.lfs.2022.121148_bb0440","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fendo.2018.00351","article-title":"FGF23 in cardiovascular disease: innocent bystander or active mediator","volume":"9","author":"St\u00f6hr","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0445","doi-asserted-by":"crossref","first-page":"770-7","DOI":"10.1080\/0886022X.2019.1650065","article-title":"Relationship of matrix Gla protein and vitamin K with vascular calcification in hemodialysis patients","volume":"41","author":"Mizuiri","year":"2019","journal-title":"Ren. Fail."},{"issue":"9","key":"10.1016\/j.lfs.2022.121148_bb0450","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.119.044195","article-title":"Slowing progression of cardiovascular calcification with SNF472 in patients on hemodialysis: results of a randomized phase 2b study","volume":"141","author":"Raggi","year":"2020","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0455","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40620-018-0471-9","article-title":"SNF472, a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels","volume":"31","author":"Perell\u00f3","year":"2018","journal-title":"J. Nephrol."},{"issue":"19","key":"10.1016\/j.lfs.2022.121148_bb0460","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1111\/bph.15163","article-title":"Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis","volume":"177","author":"Perell\u00f3","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2022.121148_bb0465","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ebiom.2016.01.011","article-title":"Vitamin K dependent protection of renal function in multi-ethnic population studies","volume":"4","author":"Wei","year":"2016","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0470","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1159\/000366400","article-title":"Vascular calcification in chronic kidney disease is induced by bone morphogenetic protein-2 via a mechanism involving the Wnt\/\u03b2-catenin pathway","volume":"34","author":"Rong","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0475","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.atherosclerosis.2010.04.023","article-title":"Bone morphogenetic protein-2 may represent the molecular link between oxidative stress and vascular stiffness in chronic kidney disease","volume":"211","author":"Dalfino","year":"2010","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.lfs.2022.121148_bb0480","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/toxins11070428","article-title":"Sclerostin as regulatory molecule in vascular media calcification and the bone\u2013vascular axis","volume":"11","author":"De Mar\u00e9","year":"2019","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0485","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1479164117742316","article-title":"Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease","volume":"15","author":"Zeng","year":"2018","journal-title":"Diab. Vasc. Dis. Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0490","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0495","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000509369","article-title":"The protective role of klotho in CKD- associated cardiovascular disease","volume":"6","author":"Bi","year":"2020","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0500","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.2013.332","article-title":"Fibroblast growth factor 23 accelerates phosphate- induced vascular calcification in the absence of Klotho deficiency","volume":"85","author":"Jimbo","year":"2014","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0505","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ki.2013.471","article-title":"Fibroblast growth factor 23 and uremic vascular calcification: is it time to escalate from biomarker status to pathogenic agent?","volume":"85","author":"Moe","year":"2014","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0510","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.semnephrol.2014.09.003","article-title":"The role of klotho on vascular calcification and endothelial function in chronic kidney disease","volume":"34","author":"Vervloet","year":"2014","journal-title":"Semin. Nephrol."},{"issue":"16","key":"10.1016\/j.lfs.2022.121148_bb0515","article-title":"Matrix Gla-protein (MGP) not only inhibits calcification in large arteries but also may be renoprotective: connecting the dots","volume":"4","author":"Epstein","year":"2016","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0520","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1440-1797.2006.00660.x","article-title":"Molecular mechanisms mediating vascular calcification: role of matrix gla protein","volume":"11","author":"Proudfoot","year":"2006","journal-title":"Nephrology"},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0525","first-page":"3717","article-title":"Phytate (IP6) is a powerful agent on preventing calcification in biological fluids,usefulness in renal lithiasis treatment","volume":"19","author":"Grases","year":"1999","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-07203-x","article-title":"A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma","volume":"7","author":"Ferrer","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197061","article-title":"Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification","volume":"13","author":"Ferrer","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0540","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0898-6568(01)00129-2","article-title":"Assessing the omnipotence of inositol hexakisphosphate","volume":"13","author":"Shears","year":"2001","journal-title":"Cell. Signal."},{"issue":"9","key":"10.1016\/j.lfs.2022.121148_bb0545","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/S0968-0896(02)00162-1","article-title":"Transport of the highly charged myo-inositol hexakisphosphate molecule across the red blood cell membrane: a phase transfer and biological study","volume":"10","author":"Vincent","year":"2002","journal-title":"Bioorg. Med. Chem."},{"issue":"S2","key":"10.1016\/j.lfs.2022.121148_bb0550","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1002\/mnfr.200900099","article-title":"Phytate in foods and significance for humans: food sources, intake, processing, bioavailability, protective role and analysis","volume":"53","author":"Schlemmer","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"issue":"8","key":"10.1016\/j.lfs.2022.121148_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136560","article-title":"Relationship between urinary level of phytate and valvular calcification in an elderly population: a cross- sectional study","volume":"10","author":"Fern\u00e1ndez-Palomeque","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121148_bb0560","article-title":"SNF472, a novel anti-crystallization agent, inhibits induced calcification in an in vitro model of human aortic valve calcification","volume":"122","author":"Zabirnyk","year":"2019","journal-title":"Vasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0565","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1681\/ASN.2010020186","article-title":"The regulation of parathyroid hormone secretion and synthesis","volume":"22","author":"Kumar","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0570","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1196\/annals.1402.088","article-title":"Progress, paradox, and potential: parathyroid hormone research over five decades","volume":"1117","author":"Potts","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0575","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/joe.1.06057","article-title":"Parathyroid hormone: past and present","volume":"187","author":"Potts","year":"2005","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0580","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/j.2040-4603.2016.tb00690.x","article-title":"PTH and vitamin D","volume":"6","author":"Khundmiri","year":"2011","journal-title":"Compr. Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0585","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/sj.bjp.0704378","article-title":"Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets","volume":"134","author":"Clemens","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0590","doi-asserted-by":"crossref","first-page":"F1215","DOI":"10.1152\/ajprenal.00406.2006","article-title":"Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways","volume":"292","author":"Rashid","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0595","doi-asserted-by":"crossref","first-page":"F60","DOI":"10.1152\/ajprenal.00622.2007","article-title":"Parathyroid hormone decreases endothelial osteoprotegerin secretion: role of protein kinase A and C","volume":"296","author":"Rashid","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0600","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.ackd.2019.09.004","article-title":"Mineral bone abnormalities and vascular calcifications","volume":"26","author":"Ray","year":"2019","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.lfs.2022.121148_bb0605","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","article-title":"Adynamic bone disease: from bone to vessels in chronic kidney disease","volume":"34","author":"Bover","year":"2014","journal-title":"Semin. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0610","first-page":"135","article-title":"Adynamic bone disease\u2014bone and beyond","volume":"1","author":"Brandenburg","year":"2008","journal-title":"NDT plus"},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0615","first-page":"117","article-title":"Adynamic bone disease: an update and overview","volume":"18","author":"Coen","year":"2005","journal-title":"J. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0620","first-page":"32","article-title":"Management of adynamic bone disease in chronic kidney disease: a brief review","volume":"1","author":"Sista","year":"2016","journal-title":"J. Clin. Transl. Endocrinol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0625","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2008.09.033","article-title":"Osteoprotegerin, vascular calcification and atherosclerosis","volume":"204","author":"Van Campenhout","year":"2009","journal-title":"Atherosclerosis"},{"issue":"9","key":"10.1016\/j.lfs.2022.121148_bb0630","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/ATVBAHA.107.147868","article-title":"Role of osteoprotegerin in arterial calcification: development of new animal model","volume":"27","author":"Orita","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.lfs.2022.121148_bb0635","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev."},{"issue":"11","key":"10.1016\/j.lfs.2022.121148_bb0640","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.RES.0000149165.99974.12","article-title":"Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin","volume":"95","author":"Collin-Osdoby","year":"2004","journal-title":"Cir. Res."},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0645","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.ki.5002355","article-title":"Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease","volume":"72","author":"Mehrotra","year":"2007","journal-title":"Kidney Int."},{"issue":"15","key":"10.1016\/j.lfs.2022.121148_bb0650","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1074\/jbc.M210868200","article-title":"Structural basis of calcification inhibition by \u03b12-HS glycoprotein\/fetuin-a: formation of colloidal calciprotein particles","volume":"278","author":"Heiss","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0655","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/ndt\/gfr382","article-title":"Serum fetuin-A and vitamin D in children with mild-to-severe chronic kidney disease: a cross-sectional study","volume":"27","author":"Schaible","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0660","doi-asserted-by":"crossref","DOI":"10.17219\/acem\/82517","article-title":"The importance of fetuin-a in vascular calcification in children with chronic kidney disease","volume":"28","author":"Makulska","year":"2019","journal-title":"Adv.Clin. Exp. Med."},{"issue":"10","key":"10.1016\/j.lfs.2022.121148_bb0665","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1681\/ASN.2004100895","article-title":"Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification","volume":"16","author":"Reynolds","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2022.121148_bb0670","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2147\/CIA.S138002","article-title":"Bisphosphonates, atherosclerosis and vascular calcification: update and systematic review of clinical studies","volume":"12","author":"Caffarelli","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.lfs.2022.121148_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115751","article-title":"Is there a role for bisphosphonates in vascular calcification in chronic kidney disease?","volume":"142","author":"Hildebrand","year":"2021","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0680","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/1573403X14666180619103258","article-title":"Role of bisphosphonates in vascular calcification and bone metabolism: a clinical summary","volume":"14","author":"Dayanand","year":"2018","journal-title":"Curr. Cardiol. Rev."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0685","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.3892\/mmr.2016.5484","article-title":"Silencing of osterix expression by siRNA inhibits aldosterone induced calcification of vascular smooth muscle cells in mice","volume":"14","author":"Gong","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0690","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MAJ.0000000000000381","article-title":"Oxidized low-density lipoprotein increases bone sialoprotein expression in vascular smooth muscle cells via runt-related transcription factor 2","volume":"349","author":"Farrokhi","year":"2015","journal-title":"Am. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0695","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11883-009-0032-8","article-title":"Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification","volume":"11","author":"Cho","year":"2009","journal-title":"Curr. Atheroscler. Rep."},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0700","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.kint.2015.12.046","article-title":"Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification","volume":"1;89","author":"Paloian","year":"2016","journal-title":"Kidney Int."},{"issue":"25","key":"10.1016\/j.lfs.2022.121148_bb0705","article-title":"Osteopontin levels in patients with chronic kidney disease stage 5 on hemodialysis directly correlate with intact parathyroid hormone and alkaline phosphatase","volume":"23","author":"Druck","year":"2019","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.lfs.2022.121148_bb0710","article-title":"Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study","author":"Steinbrenner","year":"2022","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0715","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/j.ajkd.2009.01.011","article-title":"The ubiquitous nature and elusive role of phosphorus and vascular calcification","volume":"53","author":"Goldstein-Fuchs","year":"2009","journal-title":"Am. J. Kidney Dis."},{"issue":"8","key":"10.1016\/j.lfs.2022.121148_bb0720","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"7","key":"10.1016\/j.lfs.2022.121148_bb0725","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.RES.0000161997.24797.c0","article-title":"Regulation of vascular calcification: roles of phosphate and osteopontin","volume":"96","author":"Giachelli","year":"2005","journal-title":"Circ. Res."},{"issue":"14","key":"10.1016\/j.lfs.2022.121148_bb0730","doi-asserted-by":"crossref","first-page":"S300","DOI":"10.1097\/01.ASN.0000081663.52165.66","article-title":"Vascular calcification: in vitro evidence for the role of inorganic phosphate","volume":"1","author":"Giachelli","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0735","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/toxins11040213","article-title":"The key role of phosphate on vascular calcification","volume":"11","author":"Cozzolino","year":"2019","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0740","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0745","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.kint.2016.09.024","article-title":"Vascular calcification in chronic kidney disease: different bricks in the wall?","volume":"91","author":"Vervloet","year":"2017","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.lfs.2022.121148_bb0750","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0755","first-page":"1724","article-title":"The influence of phosphate, calcium and magnesium on matrix Gla-protein and vascular calcification: a systematic review","volume":"33","author":"Houben","year":"2016","journal-title":"G. Ital. Nefrol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0760","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1681\/ASN.2016030317","article-title":"Arterial and cellular inflammation in patients with CKD","volume":"28","author":"Moens","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0765","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1053\/j.ajkd.2011.07.020","article-title":"The role of phosphorus in the development and progression of vascular calcification","volume":"58","author":"Kendrick","year":"2011","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"10.1016\/j.lfs.2022.121148_bb0770","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1097\/01.ASN.0000025782.24383.0D","article-title":"The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats","volume":"13","author":"Cozzolino","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0775","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.RES.84.2.166","article-title":"Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin","volume":"84","author":"Wada","year":"1999","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0780","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0735-1097(01)01781-8","article-title":"Cardiac calcification in adult hemodialysis patients: a link between end- stage renal disease and cardiovascular disease?","volume":"39","author":"Raggi","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0785","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jvn.2017.01.003","article-title":"Effects of serum phosphorus on vascular calcification in a healthy, adult population: a systematic review","volume":"35","author":"Sheridan","year":"2017","journal-title":"J. Vasc. Nurs."},{"issue":"22","key":"10.1016\/j.lfs.2022.121148_bb0790","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehs152","article-title":"Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography","volume":"33","author":"Shin","year":"2012","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0795","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3945\/ajcn.110.001974","article-title":"Lower concentrations of serum phosphorus within the normal range could be associated with less calcification of the coronary artery in Koreans with normal renal function","volume":"94","author":"Park","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.lfs.2022.121148_bb0800","author":"Goyal","year":"2019","journal-title":"Hyperphosphatemia"},{"key":"10.1016\/j.lfs.2022.121148_bb0805","article-title":"Phosphate, pyrophosphate, and vascular calcification: a question of balance","author":"Villa-Bellosta","year":"2017","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.lfs.2022.121148_bb0810","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/ki.2008.644","article-title":"The emerging role of phosphate in vascular calcification","volume":"75","author":"Giachelli","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2022.121148_bb0815","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1681\/ASN.2004060495","article-title":"Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice","volume":"1;16(1)","author":"Massy","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0820","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1159\/000485874","article-title":"High phosphate-induced calcification of vascular smooth muscle cells is associated with the TLR4\/NF-\u03bab signaling pathway","volume":"42","author":"Zhang","year":"2017","journal-title":"Kidney Blood Press. Res."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0825","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/acel.12322","article-title":"Relation between TLR4\/NF-\u03baB signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability","volume":"14","author":"Gargiulo","year":"2015","journal-title":"Aging Cell"},{"issue":"10","key":"10.1016\/j.lfs.2022.121148_bb0830","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fendo.2019.00603","article-title":"TLR4\/NF-\u03baB signaling induces GSDMD-related pyroptosis in tubular cells in diabetic kidney disease","volume":"19","author":"Wang","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0835","first-page":"1","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.lfs.2022.121148_bb0840","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3389\/fimmu.2019.00815","article-title":"NF\u03baB and kidney injury","volume":"16","author":"Song","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0845","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/ajh\/hpu225","article-title":"Inflammatory cytokines and reactive oxygen species as mediators of chronic kidney disease-related vascular calcification","volume":"28","author":"Agharazii","year":"2015","journal-title":"Am. J. Hypertens."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0850","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3390\/cells9061348","article-title":"Hu, NF-\u03baB and tPA signaling in kidney and other diseases","volume":"9","author":"White","year":"2020","journal-title":"Cells."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0855","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/CS20190895","article-title":"Inflammation: a putative link between phosphate metabolism and cardiovascular disease","volume":"35","author":"Voelkl","year":"2021","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-015-0056-4","article-title":"NF-\u03baB in inflammation and renal diseases","volume":"5","author":"Zhang","year":"2015","journal-title":"Cell Biosci."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0865","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1159\/000485874","article-title":"High phosphate-induced calcification of vascular smooth muscle cells is associated with the TLR4\/NF-\u03bab signaling pathway","volume":"42","author":"Zhang","year":"2017","journal-title":"KidneyBlood Press. Res."},{"key":"10.1016\/j.lfs.2022.121148_bb0870","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.ATV.17.6.1135","article-title":"Parathyroid hormone-related peptide as a local regulator of vascular calcification.Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells","volume":"17","author":"Jono","year":"1997","journal-title":"Arterioscl. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0875","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/ki.2013.26","article-title":"Key vitamin in controlling vascular calcification in chronic kidney disease","volume":"83","author":"Schurgers","year":"2013","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0880","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/17843286.2016.1180770","article-title":"The role of vitamin K in vascular calcification of patients with chronic kidney disease","volume":"1;71","author":"Wuyts","year":"2016","journal-title":"Acta Clin. Belg."},{"issue":"9","key":"10.1016\/j.lfs.2022.121148_bb0885","doi-asserted-by":"crossref","first-page":"077","DOI":"10.1093\/cdn\/nzz077","article-title":"Vascular calcification, and chronic kidney disease: current evidence and unanswered questions","volume":"3","author":"Shea","year":"2019","journal-title":"Curr. Dev. Nutr."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0890","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOL.0b013e328011c6fc","article-title":"Vitamin D and vascular calcification","volume":"18","author":"Zittermann","year":"2007","journal-title":"Curr. Opin. Lipidol."},{"issue":"13","key":"10.1016\/j.lfs.2022.121148_bb0895","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.CIR.98.13.1302","article-title":"1, 25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone\u2013related peptide","volume":"29;98","author":"Jono","year":"1998","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0900","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1681\/ASN.2007080854","article-title":"Mechanisms of vascular calcification in chronic kidney disease","volume":"19","author":"Moe","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.lfs.2022.121148_bb0905","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1681\/ASN.V12112511","article-title":"Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure","volume":"12","author":"Cozzolino","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0910","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/ndt\/gfv111","article-title":"Vascular calcification in chronic kidney disease: an update","volume":"31","author":"Schlieper","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.lfs.2022.121148_bb0915","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1523-1755.2005.00421.x","article-title":"Pathogenesis of vascular calcification in chronic kidney disease","volume":"68","author":"Cozzolino","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2022.121148_bb0920","series-title":"Endocrine FGFs And Klothos","first-page":"107","article-title":"FGF23 in chronic kidney disease","author":"Wahl","year":"2012"},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0925","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000452880","article-title":"Klotho\/FGF23 axis in chronic kidney disease and cardiovascular disease","volume":"3","author":"Lu","year":"2017","journal-title":"Kidney Dis."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41100-016-0032-4","article-title":"FGF23-klotho axis in CKD","volume":"2","author":"Takashi","year":"2016","journal-title":"Ren. Replace. Ther."},{"key":"10.1016\/j.lfs.2022.121148_bb0935","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.2009.405","article-title":"Clinical relevance of FGF-23 in chronic kidney disease","volume":"76","author":"Seiler","year":"2009","journal-title":"Kidney Int."},{"issue":"9","key":"10.1016\/j.lfs.2022.121148_bb0940","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the mild to moderate kidney disease (MMKD) study","volume":"18","author":"Fliser","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0945","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ki.2012.327","article-title":"Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community","volume":"83","author":"\u00c4rnl\u00f6v","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2022.121148_bb0950","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/872193","article-title":"Soluble \u03b1-klotho serum levels in chronic kidney disease","author":"Rotondi","year":"2015","journal-title":"Int. J. Endocrinol."},{"issue":"18","key":"10.1016\/j.lfs.2022.121148_bb0955","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.053405","article-title":"Vascular klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23","volume":"125","author":"Lim","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.lfs.2022.121148_bb0960","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2174\/0929867325666180716104159","article-title":"The role of matrix Gla protein (MGP) in vascular calcification","volume":"27","author":"Bj\u00f8rklund","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.lfs.2022.121148_bb0965","unstructured":". clinicaltrials.gov."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0970","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000476001","article-title":"Urinary osteopontin predicts incident chronic kidney disease, while plasma osteopontin predicts cardiovascular death in elderly men","volume":"7","author":"Feldreich","year":"2017","journal-title":"Cardiorenal Med."},{"issue":"1","key":"10.1016\/j.lfs.2022.121148_bb0975","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-82072-z","article-title":"Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3\u20135","volume":"11","author":"Marques","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2022.121148_bb0980","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","article-title":"Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure","volume":"39","author":"Kazama","year":"2002","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.lfs.2022.121148_bb0985","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.tcm.2007.02.005","article-title":"Vascular calcification and fetuin-A deficiency in chronic kidney disease","volume":"17","author":"Westenfeld","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.lfs.2022.121148_bb0990","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2215\/CJN.06150710","article-title":"Serum fetuin-A levels are associated with vascular calcifications and predict cardiovascular events in renal transplant recipients","volume":"6","author":"Mar\u00e9chal","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb0995","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1111\/j.1523-1755.2005.00333.x","article-title":"Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD)","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.lfs.2022.121148_bb1000","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/ndt\/gfp723","article-title":"Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4","volume":"25","author":"Ford","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"209","key":"10.1016\/j.lfs.2022.121148_bb1005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.lfs.2018.08.016","article-title":"Important roles of the Ca2+-sensing receptor in vascular health and disease","volume":"15","author":"Guo","year":"2018","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.lfs.2022.121148_bb1010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1681\/ASN.2021040585","article-title":"Impaired mineral ion metabolism in a mouse model of targeted calcium-sensing receptor (CaSR) deletion from vascular smooth muscle cells","volume":"33","author":"Schepelmann","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"issue":"235","key":"10.1016\/j.lfs.2022.121148_bb1015","first-page":"34","article-title":"Associations between single nucleotide polymorphisms in the calcium sensing receptor and chronic kidney disease-mineral and bone disorder in cats","volume":"1","author":"Geddes","year":"2018","journal-title":"Open Vet. J."},{"issue":"8","key":"10.1016\/j.lfs.2022.121148_bb1020","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/ph15080952","article-title":"Role of calcimimetics in treating bone and mineral disorders related to chronic kidney disease","volume":"15","author":"Hou","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.lfs.2022.121148_bb1025","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"209","key":"10.1016\/j.lfs.2022.121148_bb1030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.lfs.2018.08.016","article-title":"Important roles of the Ca2+-sensing receptor in vascular health and disease","volume":"15","author":"Guo","year":"2018","journal-title":"Life Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522008487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522008487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:02:07Z","timestamp":1758402127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522008487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":206,"alternative-id":["S0024320522008487"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121148","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121148","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121148"}}